[
  {
    "ts": null,
    "headline": "Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235",
    "summary": "Mizuho  analyst Ann Hynes   maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the price target from $210 to $235.",
    "url": "https://finnhub.io/api/news?id=30cabf0e594205feec08afe01db42ccbd461de54b5ad307bd646e8a20401a5a4",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770888236,
      "headline": "Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235",
      "id": 139058044,
      "image": "",
      "related": "DGX",
      "source": "Benzinga",
      "summary": "Mizuho  analyst Ann Hynes   maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the price target from $210 to $235.",
      "url": "https://finnhub.io/api/news?id=30cabf0e594205feec08afe01db42ccbd461de54b5ad307bd646e8a20401a5a4"
    }
  }
]